Concepedia

Travis Drow

TD

Statistics

Publications

4

Citations

146

H-Index

4

Active since

2022

Affiliations

University of Washington(Current)

Travis Drow is an author at University of Washington specializing in cellular therapies, diabetes, and immune regulation.

ORCID

Top concepts

Publications per year

2022–2024

4

Publications

4

Pancreatic islet-specific engineered T <sub>regs</sub> exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models

Soo Jung Yang, Akhilesh K. Singh, Travis Drow et al. · Science Translational Medicine · 2022 · 68 citations

GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes

Gene Uenishi, Marko Repic, Jennifer Yam et al. · JCI Insight · 2024 · 40 citations · Full text

, , +26

A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cells

Peter J. Cook, Su Jung Yang, Gene Uenishi et al. · Molecular Therapy · 2023 · 23 citations · Full text

Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression

Pradyut K. Paul, Rahul Das, Travis Drow et al. · American Journal of Transplantation · 2022 · 15 citations · Full text

1–4 of 4